Connection

David Morrow to Humans

Back to Details
This is a "connection" page, showing publications David Morrow has written about Humans.
David Morrow
Connection Strength
0.166
Humans
  1. Diagnosis, Management, and Pathophysiology of Arterial and Venous Thrombosis in COVID-19. JAMA. 2020 Dec 22; 324(24):2548-2549.
    View in: PubMed
    Score: 0.007
  2. Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial. Eur Heart J. 2019 10 21; 40(40):3345-3352.
    View in: PubMed
    Score: 0.007
  3. Biomarkers and Clinical Cardiovascular Outcomes With Ezetimibe in the IMPROVE-IT Trial. J Am Coll Cardiol. 2019 08 27; 74(8):1057-1068.
    View in: PubMed
    Score: 0.007
  4. Will Cardiac Intensive Care Unit Admissions Warrant Appropriate Use Criteria in the Future? Circulation. 2019 07 23; 140(4):267-269.
    View in: PubMed
    Score: 0.007
  5. Classification of Deaths in Cardiovascular Outcomes Trials. Circulation. 2019 02 12; 139(7):874-876.
    View in: PubMed
    Score: 0.006
  6. RESPONSE: Training in Critical Care Cardiology: Navigating a Field in Transition. J Am Coll Cardiol. 2018 09 04; 72(10):1174-1175.
    View in: PubMed
    Score: 0.006
  7. Serial Measurement of Natriuretic Peptides and Cardiovascular Outcomes in Patients With Type 2 Diabetes in the EXAMINE Trial. Diabetes Care. 2018 07; 41(7):1510-1515.
    View in: PubMed
    Score: 0.006
  8. De-escalation of support with veno-arterial extracorporeal membrane oxygenation and Impella for cardiogenic shock. Eur J Heart Fail. 2018 03; 20(3):621-622.
    View in: PubMed
    Score: 0.006
  9. Trends in Cardiac Critical Care: Reshaping the Cardiac Intensive Care Unit. Circ Cardiovasc Qual Outcomes. 2017 08; 10(8):e004010.
    View in: PubMed
    Score: 0.006
  10. Comment on: Progression-Free Survival as a Surrogate for Overall Survival in Clinical Trials of Targeted Therapy in Advanced Solid Tumors. Drugs. 2017 07; 77(10):1137-1138.
    View in: PubMed
    Score: 0.006
  11. Acute Myocardial Infarction. N Engl J Med. 2017 05 25; 376(21):2053-2064.
    View in: PubMed
    Score: 0.006
  12. Clinician's Guide to Early Rule-Out Strategies With High-Sensitivity Cardiac Troponin. Circulation. 2017 04 25; 135(17):1612-1616.
    View in: PubMed
    Score: 0.006
  13. Baseline adiponectin concentration and clinical outcomes among patients with diabetes and recent acute coronary syndrome in the EXAMINE trial. Diabetes Obes Metab. 2017 07; 19(7):962-969.
    View in: PubMed
    Score: 0.006
  14. Serial Measurement of High-Sensitivity Troponin I and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus in the EXAMINE Trial (Examination of Cardiovascular Outcomes With Alogliptin Versus Standard of Care). Circulation. 2017 May 16; 135(20):1911-1921.
    View in: PubMed
    Score: 0.006
  15. High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2°P - TIMI 50 Trial. Clin Chem. 2017 Jan; 63(1):307-315.
    View in: PubMed
    Score: 0.006
  16. Impact of biomarkers, proteomics, and genomics in cardiovascular disease. Clin Chem. 2012 Jan; 58(1):1-2.
    View in: PubMed
    Score: 0.004
  17. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation. 2007 Apr 03; 115(13):e356-75.
    View in: PubMed
    Score: 0.003
  18. Potent inhibition of thrombin with a monoclonal antibody against tissue factor (Sunol-cH36): results of the PROXIMATE-TIMI 27 trial. Eur Heart J. 2005 Apr; 26(7):682-8.
    View in: PubMed
    Score: 0.002
  19. Trends in Patient Characteristics and COVID-19 In-Hospital Mortality in the United States During the COVID-19 Pandemic. JAMA Netw Open. 2021 05 03; 4(5):e218828.
    View in: PubMed
    Score: 0.002
  20. Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial. JAMA. 2020 12 01; 324(21):2165-2176.
    View in: PubMed
    Score: 0.002
  21. Safety Assessment of a Noninvasive Respiratory Protocol for Adults With COVID-19. J Hosp Med. 2020 12; 15(12):734-738.
    View in: PubMed
    Score: 0.002
  22. Racial and Ethnic Differences in Presentation and Outcomes for Patients Hospitalized With COVID-19: Findings From the American Heart Association's COVID-19 Cardiovascular Disease Registry. Circulation. 2021 06 15; 143(24):2332-2342.
    View in: PubMed
    Score: 0.002
  23. Rationale and Design of ORCHID: A Randomized Placebo-controlled Clinical Trial of Hydroxychloroquine for Adults Hospitalized with COVID-19. Ann Am Thorac Soc. 2020 09; 17(9):1144-1153.
    View in: PubMed
    Score: 0.002
  24. A current review of COVID-19 for the cardiovascular specialist. Am Heart J. 2020 08; 226:29-44.
    View in: PubMed
    Score: 0.002
  25. COVID-19 and Disruptive Modifications to Cardiac Critical Care Delivery: JACC Review Topic of the Week. J Am Coll Cardiol. 2020 07 07; 76(1):72-84.
    View in: PubMed
    Score: 0.002
  26. Demographics, Care Patterns, and Outcomes of Patients Admitted to Cardiac Intensive Care Units: The Critical Care Cardiology Trials Network Prospective North American Multicenter Registry of Cardiac Critical Illness. JAMA Cardiol. 2019 09 01; 4(9):928-935.
    View in: PubMed
    Score: 0.002
  27. Derivation and Validation of a Novel Cardiac Intensive Care Unit Admission Risk Score for Mortality. J Am Heart Assoc. 2019 09 03; 8(17):e013675.
    View in: PubMed
    Score: 0.002
  28. Efficacy and safety of more potent antiplatelet therapy with vorapaxar in patients with impaired renal function. J Thromb Thrombolysis. 2019 Apr; 47(3):353-360.
    View in: PubMed
    Score: 0.002
  29. Vorapaxar for secondary prevention in the elderly with peripheral artery disease: Insights from the TRA 2°P-TIMI 50 trial. Vasc Med. 2019 04; 24(2):159-161.
    View in: PubMed
    Score: 0.002
  30. Implementation of an Emergency Department High-Sensitivity Troponin Chest Pain Pathway in the United States. Crit Pathw Cardiol. 2019 03; 18(1):1-4.
    View in: PubMed
    Score: 0.002
  31. Klotho, fibroblast growth factor-23, and the renin-angiotensin system - an analysis from the PEACE trial. Eur J Heart Fail. 2019 04; 21(4):462-470.
    View in: PubMed
    Score: 0.002
  32. Fourth Universal Definition of Myocardial Infarction (2018). Circulation. 2018 11 13; 138(20):e618-e651.
    View in: PubMed
    Score: 0.002
  33. Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure. N Engl J Med. 2019 02 07; 380(6):539-548.
    View in: PubMed
    Score: 0.002
  34. Modes and timing of death in 66 252 patients with non-ST-segment elevation acute coronary syndromes enrolled in 14 TIMI trials. Eur Heart J. 2018 11 07; 39(42):3810-3820.
    View in: PubMed
    Score: 0.002
  35. Relation of Serum and Urine Renal Biomarkers to Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Recent Acute Coronary Syndromes (From the EXAMINE Trial). Am J Cardiol. 2019 02 01; 123(3):382-391.
    View in: PubMed
    Score: 0.002
  36. Positive Pressure Ventilation in the Cardiac Intensive Care Unit. J Am Coll Cardiol. 2018 09 25; 72(13):1532-1553.
    View in: PubMed
    Score: 0.002
  37. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol. 2018 10 30; 72(18):2231-2264.
    View in: PubMed
    Score: 0.002
  38. Fourth Universal Definition of Myocardial Infarction (2018). Glob Heart. 2018 12; 13(4):305-338.
    View in: PubMed
    Score: 0.002
  39. Progressive myocardial injury is associated with mortality in the acute respiratory distress syndrome. J Crit Care. 2018 12; 48:26-31.
    View in: PubMed
    Score: 0.002
  40. Phase IIb Trial of an a7 Nicotinic Receptor Partial Agonist With and Without Nicotine Patch for Withdrawal-Associated Cognitive Deficits and Tobacco Abstinence. J Clin Psychopharmacol. 2018 Aug; 38(4):307-316.
    View in: PubMed
    Score: 0.002
  41. Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical Trial. JAMA Cardiol. 2018 06 01; 3(6):473-480.
    View in: PubMed
    Score: 0.002
  42. Validation of the Seattle angina questionnaire in women with ischemic heart disease. Am Heart J. 2018 07; 201:117-123.
    View in: PubMed
    Score: 0.002
  43. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials. J Am Coll Cardiol. 2018 03 06; 71(9):1021-1034.
    View in: PubMed
    Score: 0.002
  44. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials. Circulation. 2018 02 27; 137(9):961-972.
    View in: PubMed
    Score: 0.002
  45. Kidney Biomarkers and Decline in eGFR in Patients with Type 2 Diabetes. Clin J Am Soc Nephrol. 2018 03 07; 13(3):398-405.
    View in: PubMed
    Score: 0.002
  46. Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial. Am Heart J. 2018 04; 198:145-151.
    View in: PubMed
    Score: 0.002
  47. [Fourth universal definition of myocardial infarction (2018)]. Kardiol Pol. 2018; 76(10):1383-1415.
    View in: PubMed
    Score: 0.001
  48. Risk Assessment in Patients With Diabetes With the TIMI Risk Score for Atherothrombotic Disease. Diabetes Care. 2018 03; 41(3):577-585.
    View in: PubMed
    Score: 0.001
  49. A randomized controlled trial of resistance and endurance exercise in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2018 05; 19(3-4):250-258.
    View in: PubMed
    Score: 0.001
  50. Frequency, Predictors, and Impact of Combined Antiplatelet Therapy on Venous Thromboembolism in Patients With Symptomatic Atherosclerosis. Circulation. 2018 02 13; 137(7):684-692.
    View in: PubMed
    Score: 0.001
  51. Interleukin-6 and the Risk of Adverse Outcomes in Patients After an Acute Coronary Syndrome: Observations From the SOLID-TIMI 52 (Stabilization of Plaque Using Darapladib-Thrombolysis in Myocardial Infarction 52) Trial. J Am Heart Assoc. 2017 Oct 24; 6(10).
    View in: PubMed
    Score: 0.001
  52. Soluble interleukin-13ra1: a circulating regulator of glucose. Am J Physiol Endocrinol Metab. 2017 12 01; 313(6):E663-E671.
    View in: PubMed
    Score: 0.001
  53. Nonlinear Imputation of PaO2/FIO2 From SpO2/FIO2 Among Mechanically Ventilated Patients in the ICU: A Prospective, Observational Study. Crit Care Med. 2017 Aug; 45(8):1317-1324.
    View in: PubMed
    Score: 0.001
  54. Organizational Structure, Staffing, Resources, and Educational Initiatives in Cardiac Intensive Care Units in the United States: An American Heart Association Acute Cardiac Care Committee and American College of Cardiology Critical Care Cardiology Working Group Cross-Sectional Survey. Circ Cardiovasc Qual Outcomes. 2017 08; 10(8):e003864.
    View in: PubMed
    Score: 0.001
  55. Ranolazine in Symptomatic Diabetic Patients Without Obstructive Coronary Artery Disease: Impact on Microvascular and Diastolic Function. J Am Heart Assoc. 2017 May 04; 6(5).
    View in: PubMed
    Score: 0.001
  56. Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention. J Am Coll Cardiol. 2017 Feb 28; 69(8):911-921.
    View in: PubMed
    Score: 0.001
  57. Death or revascularization among nonadmitted ED patients with low-positive vs negative troponin T results. Am J Emerg Med. 2014 Aug; 32(8):923-8.
    View in: PubMed
    Score: 0.001
  58. National Academy of Clinical Biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure. Clin Chem. 2007 Dec; 53(12):2086-96.
    View in: PubMed
    Score: 0.001
  59. Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes. Circulation. 2006 Aug 08; 114(6):550-7.
    View in: PubMed
    Score: 0.001
  60. Correlation between the TIMI risk score and high-risk angiographic findings in non-ST-elevation acute coronary syndromes: observations from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial. Am Heart J. 2005 May; 149(5):846-50.
    View in: PubMed
    Score: 0.001
  61. Abnormal bone mineral accrual in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab. 2002 Sep; 87(9):4177-85.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.